Table 2.
Radiomics signature and clinical feature | Hazard Ratio* | P-value |
---|---|---|
ɑ-fetoprotein level | 1.67 (1.11-2.53) | 0.01# |
InverseDifferenceMoment_AllDirection_offset4_SD (art) | 0.72 (0.47-1.09) | 0.12 |
Compactness1 (art) | 0.65 (0.43-0.97) | 0.04# |
ClusterShade_AllDirection_offset1 (por) | 2.53 (1.58-4.48) | <0.005# |
ZonePercentage (por) | 1.73 (1.20-2.48) | <0.005# |
Note.-HCC: hepatocellular carcinoma, art: late arterial phase, por: portal venous phase;
*Numbers in parentheses are 95% confidence intervals;
#Statistically significant.